What are the challenges in nanomaterial commercialization? 

The primary challenges include: scaling production from laboratory to manufacturing volumes while maintaining quality; high development costs and long timelines (traditionally 5 years); regulatory approval for medical and consumer applications; achieving cost-effective production; ensuring consistent batch-to-batch quality; and addressing safety and environmental concerns. Modern continuous flow manufacturing platforms address many of these challenges by reducing scale-up time to 6 months and investment costs by up to 86%.